Project: Developing a Fast-Track COVID-19 Vaccine and an Antibody ELISA Assay with High Specificity and Sensitivity [Funder: NSHA Research & Innovation, Dalhousie Medical Research Foundation, QEII Health Sciences Centre Foundation, IWK Foundation, DGHF, RNS]
- Funded by Other Funders (Canada)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Other Funders (Canada)Principal Investigator
Dr Jun Wang Jun WangResearch Location
CanadaLead Research Institution
Dalhousie UniversityResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This study will determine whether a pentavalent COVID-19 vaccine can be quickly developed by formulating SARS-CoV-2 antigen with a commercial quadrivalent influenza virus vaccine